Article info

Original research
Orphan nuclear receptor TLX promotes immunosuppression via its transcriptional activation of PD-L1 in glioma

Authors

  • Jiayi Zhou Shenzhen Key Laboratory of Viral Oncology, The Clinical Innovation & Research Center (CIRC), Shenzhen Hospital, Southern Medical University, Shenzhen, Guangdong, ChinaThe Third School of Clinical Medicine, Southern Medical University, Shenzhen, Guangdong, China PubMed articlesGoogle scholar articles
  • Xiaojuan Pei Department of Pathology, Shenzhen Hospital, Southern Medical University, Shenzhen, Guandong, China PubMed articlesGoogle scholar articles
  • Yingui Yang Shenzhen Key Laboratory of Viral Oncology, The Clinical Innovation & Research Center (CIRC), Shenzhen Hospital, Southern Medical University, Shenzhen, Guangdong, ChinaThe Third School of Clinical Medicine, Southern Medical University, Shenzhen, Guangdong, China PubMed articlesGoogle scholar articles
  • Zhu Wang Department of Urology, People’s Hospital of Longhua, Southern Medical University, Shenzhen, Guangdong, China PubMed articlesGoogle scholar articles
  • Weijie Gao School of Biomedical Sciences, The Chinese University of Hong Kong, Hongkong, China PubMed articlesGoogle scholar articles
  • Ran Ye Shenzhen Key Laboratory of Viral Oncology, The Clinical Innovation & Research Center (CIRC), Shenzhen Hospital, Southern Medical University, Shenzhen, Guangdong, ChinaThe Third School of Clinical Medicine, Southern Medical University, Shenzhen, Guangdong, China PubMed articlesGoogle scholar articles
  • Xiantong Zhang Shenzhen Key Laboratory of Viral Oncology, The Clinical Innovation & Research Center (CIRC), Shenzhen Hospital, Southern Medical University, Shenzhen, Guangdong, ChinaThe Third School of Clinical Medicine, Southern Medical University, Shenzhen, Guangdong, China PubMed articlesGoogle scholar articles
  • Jiangang Liu Department of Neurosurgery, Shenzhen Hospital, Southern Medical University, Shenzhen, Guangdong, China PubMed articlesGoogle scholar articles
  • Zhuohao Liu Department of Neurosurgery, Shenzhen Hospital, Southern Medical University, Shenzhen, Guangdong, China PubMed articlesGoogle scholar articles
  • Xinzhi Yang Department of Neurosurgery, Shenzhen Hospital, Southern Medical University, Shenzhen, Guangdong, China PubMed articlesGoogle scholar articles
  • Jingli Tao Department of Pathology, Shenzhen Hospital, Southern Medical University, Shenzhen, Guandong, China PubMed articlesGoogle scholar articles
  • Chunshan Gu Hospital Management & performance Office, Shenzhen Hospital, Southern Medical University, Shenzhen, Guangdong, China PubMed articlesGoogle scholar articles
  • Wei Hu Department of Gastroenterology, Shenzhen Hospital, Southern Medical University, Shenzhen, Guangdong, China PubMed articlesGoogle scholar articles
  • Franky Lueng Chan School of Biomedical Sciences, The Chinese University of Hong Kong, Hongkong, China PubMed articlesGoogle scholar articles
  • Xin Li Shenzhen Key Laboratory of Viral Oncology, The Clinical Innovation & Research Center (CIRC), Shenzhen Hospital, Southern Medical University, Shenzhen, Guangdong, ChinaThe Third School of Clinical Medicine, Southern Medical University, Shenzhen, Guangdong, China PubMed articlesGoogle scholar articles
  • Jie Mao Department of Neurosurgery, Shenzhen Hospital, Southern Medical University, Shenzhen, Guangdong, China PubMed articlesGoogle scholar articles
  • Dinglan Wu Shenzhen Key Laboratory of Viral Oncology, The Clinical Innovation & Research Center (CIRC), Shenzhen Hospital, Southern Medical University, Shenzhen, Guangdong, ChinaThe Third School of Clinical Medicine, Southern Medical University, Shenzhen, Guangdong, China PubMed articlesGoogle scholar articles
  1. Correspondence to Dinglan Wu; wudinglan{at}163.com; Jie Mao; myw921{at}163.com; Xin Li; xinli268{at}gmail.com
View Full Text

Citation

Zhou J, Pei X, Yang Y, et al
Orphan nuclear receptor TLX promotes immunosuppression via its transcriptional activation of PD-L1 in glioma

Publication history

  • Accepted March 18, 2021
  • First published April 15, 2021.
Online issue publication 
April 15, 2021

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.